| USD millions | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | Trend | YoY |
|---|---|---|---|---|---|---|---|---|
| Revenue | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | — | |
| Cost of revenue | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | −13.1% | |
| Gross profit | 0.0 | 0.0 | (0.0) | 0.0 | (0.0) | (0.0) | +13.1% | |
| Research & development | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | — | |
| Selling, general & administrative | 1.0 | 1.1 | 1.2 | 1.1 | 1.1 | 1.5 | +35.4% | |
| Selling & marketing | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | — | |
| Operating expenses | 1.0 | 1.1 | 1.2 | 1.1 | 1.1 | 1.5 | +35.4% | |
| Operating income | (1.0) | (1.1) | (1.2) | (1.1) | (1.1) | (1.5) | −35.1% | |
| Interest expense | 0.0 | 0.0 | 0.2 | 0.0 | 0.0 | 0.0 | — | |
| Interest income | 0.1 | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 | −23.5% | |
| Other income / expense | 0.0 | 0.1 | (0.1) | 0.1 | (0.1) | 0.1 | +306.8% | |
| Pre-tax income | (1.0) | (1.0) | (1.4) | (1.1) | (1.2) | (1.4) | −18.8% | |
| Income tax | 0.0 | 0.0 | (0.0) | 0.0 | 0.0 | 0.0 | — | |
| Net income | (1.0) | (1.0) | (1.4) | (1.1) | (1.2) | (1.4) | −18.8% | |
| Discontinued operations | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | — | |
| Other net income adjustments | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | — | |
| EPS, basic (per share) | (0.00) | (0.00) | (0.00) | (0.00) | (0.00) | (0.00) | +0.0% | |
| EPS, diluted (per share) | (0.00) | (0.00) | (0.00) | (0.00) | (0.00) | (0.00) | +0.0% | |
| EBITDA | (0.9) | (0.9) | (1.2) | (1.1) | (1.2) | (1.5) | −28.9% | |
| Depreciation & amortization | 0.1 | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 | −13.1% | |
| Weighted average shares (shares) | 514,998,383 | 484,098,000 | 530,203,000 | 730,814,456 | 753,828,155 | 868,315,310 | +15.2% | |
| Weighted average diluted shares (shares) | 515,000,103 | 484,098,000 | 530,203,000 | 730,814,456 | 753,828,155 | 868,315,310 | +15.2% |
Amounts are shown in the stated units; per-share amounts and shares are unscaled. Negative amounts are in brackets.
Statements are reported in USD; the shares trade in GBP.
